Current Status of Induction of Specific Unresponsiveness to Organ Allografts

  • Anthony P. Monaco


Few, if any, purposeful attempts have been made to induce specific unresponsiveness to organ allografts in man. Nevertheless, there is an enormous experimental literature to show that attempts to induce unresponsiveness of some type in man are a reasonable undertaking. It is the purpose of this chapter to identify the principles and problems in the induction of unresponsiveness to allografts. No attempt will be made to review the enormous literature of this subject. Rather, experimental models developed and studied by our own group will be described to illustrate how clinical attempts for unresponsiveness induction could be undertaken.


Donor Bone Marrow Skin Allograft Total Lymphoid Irradiation Organ Allograft Tolerant Mouse 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Billingham RD, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 172:603, 1953.PubMedCrossRefGoogle Scholar
  2. 2.
    Kaliss N: Dynamics of immunologic enhancement. Transpl Proc 2:59, 1970.Google Scholar
  3. 3.
    Monaco AP, Wood ML, Russell PS: Studies on heterologous antilymphocyte serum in mice. III. Immunologic tolerance and chimerism produced across the H-2 locus with adult thymectomy and antilymphocyte serum. Ann NY Acad Sci 129:190, 1966.CrossRefGoogle Scholar
  4. 4.
    Hellstrom I, Hellstrom KE: microcytotoxicity assays of cell-mediated tumor immunity and blocking serum factor, in: Bloom BR, Glade PR (eds): In Vitro Methods in Cell-Mediated Immunity. New York, Academic Press, 1976, pp 533–539.Google Scholar
  5. 5.
    Wood ML, Monaco AP: Differential effect of cyclophosphamide on states of specific allograft unresponsiveness in immunosuppressed mice. Transplantation 27:186, 1979.PubMedCrossRefGoogle Scholar
  6. 6.
    Wood ML, Monaco AP: Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice. Transpl Proc 10:379, 1978.Google Scholar
  7. 7.
    Monaco AP, Wood ML, Lytle B, Barrett I: Studies on heterologous antilymphocyte serum in mice. VI Further studies on tolerance. Colloques Internationaux CNRS 190:361, 1971.Google Scholar
  8. 8.
    Monaco AP: Immunological tolerance and enhancement in experimental and clinical renal transplantation, Mexico 1972. Basel Karger, 1974, 5th International Congress Nephrology, in: Proceedings vol. 1, pp 99–109.Google Scholar
  9. 9.
    Wood ML, Heppner G., Gozzo JJ, Monaco AP: Mechanisms of augmented graft survival in mice after ALS and bone marrow infusion. Transpl Proc 5:691, 1973.Google Scholar
  10. 10.
    Monaco AP, Gozzo JJ, Wood ML, Liegeois A: Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): Tolerance by intraorgan injection. Transpl Proc 3:680, 1971.Google Scholar
  11. 11.
    Wood ML, Monaco AP, Gozzo JJ, Liegeois A: Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: Dose and timing. Transpl Proc 3:676, 1971.Google Scholar
  12. 12.
    Gozzo JJ, Litvin DA, Monaco AP, Bhatnager YM: Fractionated bone marrow: Use of a lymphocyte containing fraction for skin allograft prolongation in ALS treated mice. Transpl Proc 13:592, 1981.Google Scholar
  13. 13.
    Caridis DT, Liegeois A, Barrett I, Monaco AP: Enhanced survival of canine renal allografts of ALS-treated dogs given bone marrow. Transpl Proc 5:671, 1973.Google Scholar
  14. 14.
    Monaco AP, Clark AW, Wood ML, Sahyoun AI, Codish SD, Brown RW: Possible active enhancement of a human cadaver renal allograft with antilymphocyte serum (ALS) and donor bone marrow: Case report of an initial attempt. Ann Surg 79:384, 1976.Google Scholar
  15. 15.
    Strober S, Slavin S, Fuks Z, Kaplan HS, Gottlieb M. Bieber C, Hoppe RT, Grumet FC: Transplantation tolerance after total lymphoid irradiation. Proc 11:1032, 1979.Google Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • Anthony P. Monaco
    • 1
  1. 1.Cancer Research InstituteNew England Deaconness HospitalBostonUSA

Personalised recommendations